InvestorsHub Logo
Followers 17
Posts 735
Boards Moderated 0
Alias Born 02/05/2004

Re: None

Saturday, 07/04/2015 9:27:29 PM

Saturday, July 04, 2015 9:27:29 PM

Post# of 345681
Great 47 Minute Video with Rolf Brekken
Data Presentations at ASCO Demonstrate the Ability of Peregrine Pharmaceuticals' Bavituximab to Activate Tumor Targeting Immune Cells in PD-L1 Negative NSCLC Tumors (Peregrine Pharmaceuticals Inc)
http://article.wn.com/view/2015/06/01/Data_Presentations_at_ASCO_Demonstrate_the_Ability_of_Peregr/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News